DV
Dividend Vision

BIOA — BioAge Labs, Inc.

BioAge Labs, Inc. (BIOA)

Total return is -42.1% over the past 1.9 years, 80.5 points behind SPY at 38.4%. Its deepest 1-year drawdown was 64.0%.

Based on the data provided, a comprehensive summary cannot be written at this time. BIOA appears to be a healthcare equity holding rather than an established dividend ETF, with missing critical information including fund objective, underlying holdings, distribution frequency, yield data, and expense ratio. The fund's recent inception date (September 2024) and lack of performance history limit meaningful analysis of its dividend characteristics and suitability for income-focused investors.

BIOA key facts

Asset type
Stock
Asset class
Equity
Inception date
09/26/2024
Distribution frequency
None
Last close
$10.60
Market cap
$486,507,232
Average volume
444400.0
Payout ratio
0.0
Forward P/E
0.0
EPS
$-2.39